# Weekly Vaccination With Copaxone as a Potential Therapy for Dry Age-related Macular Degeneration

> **NCT00541333** · PHASE1 · SUSPENDED · sponsor: **The New York Eye & Ear Infirmary** · enrollment: 15 (actual)

## Conditions studied

- Dry Age Related Macular Degeneration

## Interventions

- **DRUG:** Copaxone Injection

## Key facts

- **NCT ID:** NCT00541333
- **Lead sponsor:** The New York Eye & Ear Infirmary
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2007-12
- **Primary completion:** 2012-12
- **Final completion:** —
- **Target enrollment:** 15 (ACTUAL)
- **Why stopped:** Reviewing data
- **Last updated:** 2013-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00541333

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00541333, "Weekly Vaccination With Copaxone as a Potential Therapy for Dry Age-related Macular Degeneration". Retrieved via AI Analytics 2026-09-04 from https://api.ai-analytics.org/clinical/NCT00541333. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*